Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

v3.20.2
WARRANTS (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Jul. 28, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Issuance of common stock upon exercise of stock options, shares       249,578    
Fair value of warrants issued       $ 6,215,225    
Debt face amount   $ 20,000,000   $ 20,000,000  
Share-based Payment Arrangement, Tranche One [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Debt face amount $ 20,000,000          
Loan Agreement [Member] | K2 HealthVentures LLC [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants to purchase shares of common stock, exercised 86,206          
Exercise price of warrants $ 6.96          
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Debt face amount $ 50,000,000          
Warrant [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants to purchase shares of common stock, exercised   0 0 0 1,283,500  
Issuance of common stock upon exercise of stock options, shares     0   1,119,868  
Warrant [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants to purchase shares of common stock, exercised 86,206          
Exercise price of warrants $ 6.96          
Warrant expire date Jul. 28, 2030          
Fair value of warrants issued $ 472,409          
CFF Warrant [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants outstanding to purchase of common stock shares   1,000,000   1,000,000    
Exercise price of warrants   $ 13.20   $ 13.20    
Number of warrants exercisable for common stock       500,000    
CFF Warrant [Member] | Investment Agreement [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants outstanding to purchase of common stock shares   1,086,206   1,086,206    
Exercise price of warrants   $ 12.70   $ 12.70    
Weighted average remaining life of warrants       4 years 9 months 3 days    
Number of warrants exercisable for common stock       500,000    
Warrant expire date   Jan. 26, 2025   Jan. 26, 2025